SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021SARS-CoV-2 B.1.1.529(Omicron) 변종 — 미국, 2021년 12월 1~8일Full Report Published on 2021-12-172022-09-10 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] B.1.1.529 omicron SARS-CoV-2 United States [DOI] 10.15585/mmwr.mm7050e1 PMC 바로가기 [Article Type] Full Report
SARS‐CoV‐2 Omicron variant: Characteristics and preventionPerspective Published on 2021-12-162022-10-30 Journal: MedComm [Category] COVID-19, [키워드] accumulated ACE2 acute respiratory syndrome B.1.1.529 Beta Characteristics coronavirus Coronavirus disease 2019 COVID‐19 delta variant described enzyme FIVE Gamma global public health immune evasion L452R Mutation mutations omicron overcome pathogenicity Prevalence Prevent raised rapid increase RBD receptor receptor‐binding domain reported residue SARS‐CoV‐2 South Africa substitutions T478K the RBD Transmissibility variant variants VoC VOCs WHO World Health Organization [DOI] 10.1002/mco2.110 PMC 바로가기 [Article Type] Perspective
SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States미국에서 SARS-COV-2 및 변형 진단 테스트 접근법Review Published on 2021-12-132022-09-01 Journal: Viruses [Category] SARS, 변종, 진단, 치료기술, [키워드] antibody Antibody Response Antibody responses Antigen approach approval attainment B.1.1.529 Characteristics COVID-19 detect diagnose diagnostic diagnostic testing Diversity Emergency use authorization EUA FDA finding Infection infection with SARS-CoV-2 information Laboratory Multiple nucleic acids omicron PCR performed platform provide reagent reagents recent recent findings review SARS-CoV-2 significantly subsequent Supply chain Support Testing the United State United States variant variants Viral Viral variants [DOI] 10.3390/v13122492 PMC 바로가기 [Article Type] Review
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistanceArticle Published on 2021-12-012022-10-28 Journal: ArXiv [Category] COVID-19, [키워드] acute respiratory syndrome antibody resistance antibody-resistance appear B.1.1.529 Celltrion Complete Complexes contagious coronavirus COVID-19 delta variant domain drug Efficacy food Infectivity Lilly mAb mAbs Mild monoclonal antibody Mutation mutations omicron Panic Protein Quantitative analysis RBD Regeneron response reveal SARS-CoV-2 Structure the SARS-CoV-2 university Vaccine Vaccine breakthrough variant virus PMC 바로가기 [Article Type] Article